US specialty chemicals producer Ashland has signed a definitive agreement to sell its nutraceuticals business to Turnspire Capital Partners. The transaction is expected...

US specialty chemicals producer Ashland has announced that it will start a divestiture process for the company’s nutraceuticals business.